Charles Riv Lab Rg
CRL
USD
STOCK MARKET:
NYX
Closed
 
...
Large gap with delayed quotes
Last quote
02/14/2025 - 22:15:00
Bid
02/14/2025 - 21:59:59
Bid
Volume
Ask
02/14/2025 - 21:59:59
Ask
Volume
151.99
-1.18 ( -0.77% )
152.09
2,900
152.10
2,000
More information
Analysis by TheScreener
11.02.2025
Evaluation Slightly negative  
Interest None  
Sensibility High  
Analysis date: 11.02.2025
Global Evaluation
  Slightly negative
The stock is classified in the slightly negative zone since 10.01.2025.
Interest
  None
No stars since 21.01.2025.
Earnings Rev Trend
  Negative
 
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 21.01.2025 at a price of 169.81.
Evaluation
  Overvalued
 
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
  Negative
 
The forty day technical trend is negative since 06.12.2024.
4wk Rel Perf
  -22.51%
 
The four-week dividend-adjusted underperformance versus SP500 is 22.51%.
Sensibility
  High
The stock has been on the high-sensitivity level since 10.01.2025.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 3.70%.
Mkt Cap in $bn
  8.18
With a market capitalization >$8bn, CHARLES RIVER LAB is considered a large-cap stock.
G/PE Ratio
  0.62
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential: premium.
LT P/E
  15.31
The estimated PE is for the year 2026.
LT Growth
  9.50%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
  16
Over the last seven weeks, an average of 16 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  111
For 1% of index variation, the stock varies on average by 1.11%.
Correlation
  0.37
Stock movements are strongly independent of index variations.
Value at Risk
  37.19
The value at risk is estimated at USD 37.19. The risk is therefore 24.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  31.03.2004